SITC Resource Library

Advances in Cancer Immunotherapy™ Webinar - Clinical Updates from ASCO 2021 

09-27-2021 17:24

On October 6, 2021, leading experts in cancer immunotherapy discussed the latest advances in cancer immunotherapy emerging from ASCO 2021. The recorded webinar and presentation slides are available below.

Webinar Faculty:

  • Moderator: Evan J. Lipson, MD – Johns Hopkins University
  • Presenters:
    • Ulka Vaishampayan, MD – University of Michigan
    • Jarushka Naidoo, MBBCH, MHS – Beaumont RCSI Cancer Centre Dublin
    • Matthew Frigault, MD, MSc - Massachusetts General Hospital
Featured Presentations:

  • Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma: Randomized, double-blind, phase III KEYNOTE-564 study. - Presenter: Ulka Vaishampayan, MD
  •  First-line nivolumab (NIVO) plus ipilimumab (IPI) plus two cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients with advanced non-small cell lung cancer (NSCLC): Two-year update from CheckMate 9LA. - Presenter: Jarushka Naidoo, MBBCH, MHS
  • Ciltacabtagene autoleucel, a B-cell maturation antigen (BCMA)-directed chimeric antigen receptor T-cell (CAR-T) therapy, in relapsed/refractory multiple myeloma (R/R MM): Updated results from CARTITUDE-1. - Presenter: Matthew Frigault, MD, MSc

Please note that the on-demand webinar is not available for continuing education credits.

Statistics
0 Favorited
173 Views
2 Files
0 Shares
48 Downloads
Attachment(s)
pdf file
Advances in Cancer Immunotherapy™ Webinar - Clinical Upda...   5.16 MB   1 version
Uploaded - 10-08-2021
Moderator: Evan J. Lipson, MD – Johns Hopkins University Presenters: Ulka Vaishampayan, MD – University of Michigan, Jarushka Naidoo, MBBCH, MHS – Beaumont RCSI Cancer Centre Dublin, Matthew Frigault, MD, MSc - Massachusetts General Hospital.
mp4 file
Advances in Cancer Immunotherapy™ Webinar - Clinical Upda...   1.46 GB   1 version
Uploaded - 10-11-2021
Moderator: Evan J. Lipson, MD – Johns Hopkins University Presenters: Ulka Vaishampayan, MD – University of Michigan, Jarushka Naidoo, MBBCH, MHS – Beaumont RCSI Cancer Centre Dublin, Matthew Frigault, MD, MSc - Massachusetts General Hospital.

Related Entries and Links

No Related Resource entered.